# Johnson & Johnson (JNJ) — Q2-2011 Earnings Results

**Report date:** 2011-07-19 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2011

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down 0.55%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.28 | N/A | +3.56% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting ongoing efforts in innovation. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on innovation and operational efficiency.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Johnson & Johnson's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell slightly by 0.55%, suggesting that investors may have been looking for more comprehensive guidance or revenue details. The lack of revenue data and future guidance could have contributed to the stock's downward movement.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2011_